Molecular Partners (MOLN.SW) Priced

Swiss biotech developing protein therapies for wet AMD and solid tumors.

Health Care - Biotechnology

IPO Performance
Latest Trade $22.20 0.00 (0.0%)
First Day Return 37.8%
Return from IPO -4.4%
 
Molecular Partners IPO News more
  • .
IPO Data
IPO File Date 09/24/2014
Offer Price $23.22
Price Range $23.23 - $23.23
Offer Shares (mm) 4.4
Deal Size ($mm) 102
 
IPO Data
IPO Date 11/04/2014
Offer Price $23.22
Price Range $23.23 - $23.23
Offer Shares (mm) 4.4
Deal Size ($mm) $102
 
Underwriters
more
Business Overview
Swiss biotech developing protein therapies for wet AMD and solid tumors.
Swiss biotech developing protein therapies for wet AMD and solid tumors.
more
Company Data
Headquarters Zurich, , Switzerland
Founded 2004
Employees n/a
Website www.molecularpartners.com
 

Performance vs. IPO Index (IPOUSA)